院前无创通气治疗急性呼吸衰竭有效,即使距医院路程很短也应实施
该前瞻性研究连续纳入99例由急诊医师在院前使用无创通气(NIV)的COPD急性加重和心源性肺水肿患者,按院前NIV治疗时间分为≤15分钟组(n=41)和>15分钟组(n=58),并设30例接受标准治疗的 historic 对照组。NIV采用从持续气道正压(CPAP)到CPAP联合压力支持(CPAP-ASB)再到双水平吸气正压(BIPAP)的阶梯式升级方案,90%患者接受CPAP-ASB。与对照组相比,NIV组在心率、外周血氧饱和度、呼吸频率、收缩压和呼吸困难评分从基线到入院时的改善均显著更优(p<0.001),且两NIV组间稳定效果相当(无显著差异)。作者结论为COPD急性加重和心源性肺水肿患者应接受院前NIV治疗,即使急救现场距医院路程很短。
要点
- 对COPD急性加重和心源性肺水肿患者,院前NIV从基线到入院时在心率、外周血氧饱和度、呼吸频率、收缩压和呼吸困难评分上的改善均显著优于标准治疗对照组(p<0.001)。
- 院前NIV稳定生命体征的效果与治疗时间长短无关:≤15分钟组(13.1±3.2分钟)与>15分钟组(22.8±5.9分钟)之间无显著差异。
- NIV技术操作耗时6.1±3.8分钟;90%患者使用CPAP-ASB,8%使用单纯CPAP,2%使用BIPAP。
- 作者结论:COPD急性加重和心源性肺水肿患者应实施院前NIV治疗,即使急救现场与医院之间距离很短。
适用人群与场景
- 院前由急诊医师治疗的COPD急性加重和心源性肺水肿患者,连续前瞻性纳入。
- 对照组的来源是接受标准治疗的历史患者。
处置流程与药物剂量
- 院前NIV采用阶梯式升级方案:从持续气道正压(CPAP)开始,升级为CPAP联合压力支持(CPAP-ASB),最后升级为双水平吸气正压(BIPAP)。
- 实际应用中90%患者接受CPAP-ASB,8%接受单纯CPAP,2%接受BIPAP。
研究设计与关键结果
- 前瞻性研究共分析99例院前NIV患者(NIV组1:≤15分钟,n=41;NIV组2:>15分钟,n=58),历史对照组30例接受标准治疗。
- NIV技术操作耗时6.1±3.8分钟;NIV治疗时间:NIV组1为13.1±3.2分钟,NIV组2为22.8±5.9分钟。
- 心率、外周血氧饱和度、呼吸频率、收缩压和呼吸困难评分从基线到入院时的变化,NIV组均显著优于对照组(p<0.001)。
- 两NIV组之间生命体征稳定效果相当,不依赖治疗时间长短(无显著差异)。
证据类型、等级与局限
- 证据类型:前瞻性研究,设历史对照。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,COPD急性加重和心源性肺水肿患者应实施院前NIV治疗,即使急救现场与医院之间距离很短。
- 院前NIV可采用从CPAP到CPAP-ASB再到BIPAP的阶梯式升级方案,本研究中多数患者实际接受CPAP-ASB。
- 院前NIV稳定生命体征的效果不依赖治疗时间长短,≤15分钟与>15分钟两组间无显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: Evaluation of the efficacy of prehospital non-invasive ventilation (NIV) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and cardiogenic pulmonary edema (CPE).
MATERIAL AND METHODS: Consecutive patients who were prehospitally treated by Emergency Physicians using NIV were prospectively included. A step-by-step approach escalating NIV-application from continuous positive airway pressure (CPAP) to continuous positive airway pressure supplemented by pressure support (CPAP-ASB) and finally bilevel inspiratory positive airway pressure (BIPAP) was used. Patients were divided into two groups according to the prehospital NIV-treatment-time (NIV-group 1: ≤15 min, NIV-group 2: >15 min). In addition, a historic control group undergoing standard care was created. Endpoints were heart rate, peripheral oxygen saturation, breathing rate, systolic blood pressure, and a dyspnea score.
RESULTS: A total of 99 patients were analyzed (NIV-group 1: n = 41, NIV-group 2: n = 58). The control group consisted of 30 patients. The majority of NIV-patients (90%) received CPAP-ASB, while CPAP without ASB was conducted in 8% and BIPAP-ventilation in 2% of all cases. Technical application of NIV lasted 6.1 ± 3.8 min. NIV-treatment-time was as follows: NIV-group 1: 13.1 ± 3.2 min, NIV-group 2: 22.8 ± 5.9 min. Differences between baseline- and hospital admission values of all endpoints showed significantly better improvement in NIV-groups compared to the control group (p < 0.001). The stabilizing effect of NIV in terms of vital parameters was comparable between both NIV-groups, independent of the duration of treatment (n.s.).
CONCLUSION: Prehospital NIV-treatment should be performed in patients with COPD-exacerbation and CPE, even if the distance between emergency scene and hospital is short.
参考来源
- Hensel M, Strunden MS, Tank S, et al. Prehospital non-invasive ventilation in acute respiratory failure is justified even if the distance to hospital is short. Am J Emerg Med. 2018. PMID: 30068489. doi:10.1016/j.ajem.2018.07.001
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。